Sight Diagnostics ? is a blood diagnostic company that combines machine vision and AI to improve health through fast, convenient and accurate diagnostics.
Sight OLO ? is the first device to receive FDA clearance for a 5 part diff CBC test directly from a fingerstick sample, requiring 5% of the minimum blood volume needed for traditional lab equipment and still providing the same quality of results.
OLO digitizes blood with only 2 drops of a finger prick or venous sample and provides lab-grade CBC results in minutes.